Особливості епідемії туберкульозу на сучасному етапі

Автор(и)

  • Л. Тодоріко
  • І. Єременчук

Ключові слова:

вперше діагностований туберкульоз; мультирезистентність мікобактерій туберкульозу; хіміорезистентність

Анотація

В оглядовій статті проаналізовано особливості епідемії туберкульозу на сучасному етап.

Посилання

Zhurylo OA, Barbova AI, Klymenko MT. Diahnostychna efektyvnist' rutynnykh metodiv mikrobiolohichnoi diahnostyky tuberkul'ozu [Diagnostic efficiency of routine methods of microbiological diagnosis of tuberculosis]. Ukrains'kyi pul'monolohichnyi zhurnal. 2006;2:40-1. (in Ukrainian).

Egorov AM. Dostizhenie fundamental'nikh nauk i novye podkhodi k khimioterapii tuberkuleza [Achievement of fundamental sciences and new approaches to tuberculosis chemotherapy]. Problemy tuberkuleza. 2000;5:11-5. (in Russian).

Feschenko YuI, Petrenko VM, Cheren'ko SO. Epidemiolohiia, diahnostyka ta likuvannia khimiorezystentnoho tuberkul'ozu orhaniv dykhannia [Epidemiology, diagnosis and treatment of chemoresistant respiratory tuberculosis]. Ukrains'kyi pul'monolohichnyi zhurnal. 2002;4:5-12. (in Ukrainian).

Pavlenko OV, Novozhylova IO, Shvaienko NP. Kliniko-bakteriolohichna kharakterystyka khvorykh na tuberkul'oz lehen' z khimiorezystentnymy formamy zbudnyka [Clinical and bacteriological characteristics of patients with pulmonary tuberculosis with chemoresistant forms of the pathogen]. Ukrains'kyi pul'monolohichnyi zhurnal. 2002;4:31-3. (in Ukrainian).

Kostyk O, Purs'ka M, Il'nyts'ka L. Orhanizatsiino-mikrobiolohichni aspekty problemy mul'tyrezystentnoho tuberkul'ozu na suchasnomu etapi [Organizational-microbiological aspects of the problem of multidrug-resistant tuberculosis at the present stage]. Naukovyi visnyk Natsional'noho medychnoho universytetu im. O.O. Bohomol'tsia. 2008;2:108-9. (in Ukrainian).

Khudushina TA, Voloshina EP, Adamovich NV. Lekarstvennaya ustoychivost' mikobakteriy tuberkuleza vpervye vyyavlennykh bol'nykh tuberkulezom legkikh [Drug resistance of mycobacterium tuberculosis in newly diagnosed pulmonary tuberculosis patients]. Problemy tuberkuleza i bolezney legkikh. 2005;12:37. (in Russian).

Mel'nyk VM. Problemy standartyzatsii epidemiolohichnoho kontroliu za rezystentnistiu do antymikobakterial'nykh preparativ v Ukraini ta shliakhy yikh vyrishennia [Problems of standardization of epidemiological control of resistance to antimycobacterial drugs in Ukraine and ways of their solution]. Ukrains'kyi khimioterapevtychnyi zhurnal. 1999;3:8-11. (in Ukrainian).

Mel'nik VM, Voloshina VV. Sotsial'nye i meditsinskie problemy tuberkuleza v Ukraine [Social and medical problems of tuberculosis in Ukraine]. Problemy tuberkuleza i bolezney legkikh. 2004;2:22-4. (in Russian).

Mishin VYu, Stepanyan IE. Kontroliruemaya khimioterapiya tuberkuleza organov dykhaniya v sovremennykh usloviyakh. Problema lekarstvennoy ustoychivosti [Controlled chemotherapy for respiratory tuberculosis in modern conditions. Drug resistance problem]. Russkiy meditsinskiy zhurnal. 2000;8(12):496-500. (in Russian).

Mishin VYu. Khimioterapiya tuberkuleza legkikh [Chemotherapy for pulmonary tuberculosis]. Pul'monologiya. 2008;3:5-13. (in Russian).

Stepanshyna VM, Parfertsev YeA, Mitrofanova HN. Molekuliarni mekhanizmy ustoichyvosty k ryfampytsynu y yzonyazydu klynycheskykh shtammov Mycobacterium tuberculosis [Molecular mechanisms of resistance to rifampicin and isoniazid in clinical strains of Mycobacterium tuberculosis]. Problemy tuberkul'oza. 2000;1:32-6. (in Ukrainian).

Novozhilova IA. Znachimost' opredeleniya lekarstvennoy ustoychivosti mikobakteriy tuberkuleza dlya uspeshnogo lecheniya tuberkuleza legkikh (diskussiya) [The importance of determining the drug resistance of mycobacterium tuberculosis for the successful treatment of pulmonary tuberculosis (discussion)]. Problemy tuberkuleza i bolezney legkikh. 2004;4:29. (in Russian).

Novozhylova IO, Pavlenko OV. Monitorynh medykamentoznoi stiikosti zbudnyka tuberkul'ozu za 1996-2000 roky [Monitoring of drug resistance of the tuberculosis agent for 1996-2000]. Ukrains'kyi pul'monolohichnyi zhurnal. 2002;3:40-2. (in Ukrainian).

Petrenko VM, Cheren'ko SO, Kuchuhura-Kuchurenko LV. Antybakterial'na terapiia khvorykh na tuberkul'oz lehen' z mul'tyrezystentnymy mikobakteriiamy tuberkul'ozu [Antibacterial therapy for patients with pulmonary tuberculosis with multidrug-resistant mycobacterium tuberculosis]. Ukrains'kyi khimioterapevtychnyi zhurnal. 2001;1:41-5. (in Ukrainian).

Purs'ka MB. Dynamika mul'tyrezystentnosti mikobakterii tuberkul'ozu v period epidemii [Dynamics of multidrug resistance of tuberculosis mycobacteria during the epidemic]. Praktychna medytsyna. 2008;14(3)137-41. (in Ukrainian).

Skotnikova OI. Kharakteristika chuvstvitel'nosti mikobakteriy Mycobacterium tuberculosis k rifampitsinu i izoniazidu pod sredstvom opredeleniya mutatsii v genakh rpoB, katG, inhA, oxyR, kasA, razlichnymi molekulyarno-biologicheskimi metodami [Characterization of the sensitivity of Mycobacterium tuberculosis mycobacteria to rifampicin and isoniazid by means of determining mutations in the rpoB, katG, inhA, oxyR, kasA genes, by various molecular biological methods]. Problemy tuberkuleza i bolezney legkikh. 2005;8:42-6. (in Russian).

Sokolova G. Sovremennye rezhimy khimioterapii tuberkuleza [Modern tuberculosis chemotherapy regimens]. Vrach. 2001;2:15-9. (in Russian).

Kheyfets LB. Mikrobiologicheskie aspekty vyyavleniya bol'nykh tuberkulezom s lekarstvennoy ustoychivost'yu [Microbiological aspects of the identification of drug-resistant tuberculosis patients]. Problemy tuberkuleza i bolezney legkikh. 2004;5:3-6. (in Russian).

Khodashova ML, Yuditskiy MV, Semenova OV. Otdalennye rezul'taty lecheniya lekarstvenno ustoychivogo tuberkuleza u sotsial'no adaptirovanykh bol'nykh [Long-term results of treatment of drug-resistant tuberculosis in socially adapted patients]. Problemy tuberkuleza i bolezney legkikh. 2004;3:26-8. (in Russian).

Cheren'ko SO. Perenosymist' khimioterapii u khvorykh na tuberkul'oz lehen' z mul'tyrezystentnymy mikobakteriiamy tuberkul'ozu [Tolerance of chemotherapy in patients with pulmonary tuberculosis with multidrug-resistant tuberculosis mycobacteria]. Ukrains'kyi pul'monolohichnyi zhurnal. 2001;1:26-8. (in Ukrainian).

Cheren'ko SO. Tryvalist' khimioterapii khvorykh na tuberkul'oz lehen' z mul'tyrezystentnymy mikobakteriiamy tuberkul'ozu [Duration of chemotherapy of patients with pulmonary tuberculosis with multidrug-resistant tuberculosis mycobacteria]. Ukrains'kyi medychnyi chasopys. 2000;5:127-30. (in Ukrainian).

Shapovalov VP. Efektyvnist' khimioterapii u khvorykh na vpershe diahnostovanyi destruktyvnyi tuberkul'oz lehen' pry fazovomu zastosuvanni zasobiv patohenetychnoho likuvannia [The effectiveness of chemotherapy in patients with newly diagnosed destructive pulmonary tuberculosis in the phase application of pathogenetic treatment]. Bukovyns'kyi medychnyi visnyk. 2006;10(3):95-8. (in Ukrainian).

Bleed D, Dye C, Raviglione M. Dynamics and control of the global tuberculosis epidemic. Curr Opin Pulm Med. 2000;6(3):174-9.

Davies PD. Tuberculosis: the global epidemic. J Indian Med Assoc. 2000;98(3):100-2.

Lodencemper R, Sagebiel D, Bredel A. Strategies against multidrugresistant tuberculosis. Eur Respir J. 2002;20(36):66-7.

Rusch-Gerdes S. Epidemiology of resistant tuberculosis in Europe. Infection. 1999;2:17-8.

Espinal MA, Kim SJ, Suares PG, Kam KM, Khomenko AG, Migliori GB, et al. Standart short – course chemoterapy for drugresistant tuberculosis. Treatment outcomes in 6 countries. JAMA. 2000;283(19):2537-45.

Yew WW. Management of multiple drugresistant tuberculosis: chemoterapy and beyond. Clin Pulm Med. 2001;8(5):265-72.

##submission.downloads##

Опубліковано

2021-12-20

Номер

Розділ

ТЕОРЕТИЧНА МЕДИЦИНА